Table 2.
Blood viral load, immune and biochemical markers in non-hemophiliac patients mean ± SEM
|
Non-hemophiliac patients |
|||
| HBV | HCV | HIV | |
| No. | 17 | 14 | 20 |
| HIV viral load1 | Not applicable | Not applicable | 1.4 × 102 (< 50-104) |
| HBV viral load | 8.8 × 106 (2.6 × 103-108) | Not applicable | Not applicable |
| HCV viral load | Not applicable | 9 × 105 (2.6 × 103-107) | Not applicable |
| CD42 | 53.53 ± 4.15 | 41.43 ± 3.04 | 18.25 ± 1.83 |
| CD4/CD8 | 1.93 ± 0.3 | 2.08 ± 0.26 | 0.63 ± 0.06 |
| ALT (U/L) | 266.6 ± 79.4 | 92.64 ± 22.6 | 34.35 ± 11.7 |
| AST (U/L) | 297.5 ± 108 | 77.5 ± 10 | 30.15 ± 3.82 |
| TBIL (mol/L) | 113.4 ± 36 | 31 ± 5.8 | 14.18 ± 1.42 |
| ALP (U/L) | 110 ± 7.9 | 118 ± 19.7 | 45.44 ± 0.63 |
| γ-GT (U/L) | 95.9 ± 17.8 | 87.6 ± 22 | 26.75 ± 5.52 |
| HA (ng/mL) | 323.2 ± 64.6 | 424.14 ± 78 | 83.9 ± 15.25 |
| CG (μg/dL) | 2678 ± 409 | 2050 ± 485 | 410 ± 61 |
| PC3 (μg/L) | 196 ± 21 | 236 ± 36 | 159.6 ± 28.4 |
| LN (ng/mL) | 122.6 ± 7.2 | 118 ± 11 | 106.65 ± 5.24 |
| IVC (ng/mL) | 100 ± 11 | 124 ± 15.6 | 74 ± 11.7 |
1
Geometric mean viral loads and range of HIV RNA, HBV DNA and HCV RNA;
2
Represented as percent of the total T cell (CD3+) population.